KVUE (Kenvue) Future Price to Earnings

Official company branding of Kenvue (KVUE)

Kenvue Inc. (KVUE) possesses significant pricing power driven by brand loyalty and faces minimal geopolitical risks. The company's valuation based on forward P/E allows for the tracking of asset revaluation phases, with the metric currently fixed at 15.40. Business stability and a focus on health attract top-tier researchers and marketers to the team, guaranteeing them a reliable professional environment.

kenvue.com - KVUE Market Cap to Future Earnings Ratio (period 02/21/2024 - 11/14/2026)

Summary analytical data breakdowns for kenvue.com (KVUE)

- current price and projected stock value:
Stock Quotes Kenvue Corp|KVUE - Fair Value Consensus
- business market valuation indicators:
Market Value Kenvue Inc|KVUE - Total Enterprise Value
- balance sheet equity data:
Accounting Value per Share Kenvue|KVUE - Total Net Assets|Market Capitalization to Book Value Ratio kenvue.com|KVUE - Aggregate Asset Value
- debt level and financial liquidity data:
Total Debt to Capital Kenvue Inc.|KVUE - Long-Term Liabilities to Capital|Short-Term Debt to Equity Kenvue|KVUE - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Kenvue Corp|KVUE - Company Long-Term Debts|Company Short-Term Debts Kenvue|Quick Liquidity kenvue.com
- financial results and valuation multiples details:
KVUE - Company Profit|Future Profit Kenvue Inc.|KVUE - Price to Earnings Ratio|Projected Price to Earnings Kenvue Health|KVUE - PEG Multiple|EV/EBITDA Multiple Kenvue Inc|KVUE - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Kenvue|KVUE - Earnings per share for the trailing year|Quarterly EPS earnings growth kenvue.com|KVUE - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Kenvue Inc.
- company sales and revenue statistics:
KVUE - Company Sales Volume|Projected Sales Volume Kenvue Health|KVUE - Market Cap to Revenue|Forward Price-to-Revenue Multiple Kenvue Inc.
Fundamental valuation:KVUE Kenvue Inc
Brand item of Kenvue Inc.

The forward P/E ratio relates the current market value of a share to the expected earnings per share. This metric allows an investor to assess the capital payback period and the sustainability of the business model in real time. By analyzing the current forward P/E of the company, one can determine the degree of asset overvaluation. For Kenvue Inc. (KVUE), the stability of this indicator confirms the pricing power of its premium brands. However, any deviations would signal margin pressures or legal risks.

Analysis of competing companies

Future Price to Earnings haleon.com (HLN)|VRNA (Verona Pharma Inc.) - Future Price to Earnings Multiple|Future Price to Earnings Jyong Biotech Limited MENS|Ligand (LGND) - Projected Price to Earnings Ratio|AMRX: Projected Price to Earnings|Perrigo - Market Cap to Future Earnings Ratio|ALVO: Forward P/E Multiple|Liquidia Technologies - Future Price to Earnings Multiple|GLPG (Galapagos N.V.) - Forward P/E Multiple|Projected Price to Earnings Ratio anipharmaceuticals.com ANIP|Future Price to Earnings MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Future Price to Earnings Multiple|Future Price to Earnings Pacira BioSciences, Inc. PCRX|Forward P/E Multiple ARS Corp SPRY|Theravance Biopharma - Forward P/E Multiple|Forward Price to Earnings Multiple Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Future Price to Earnings|Projected Price to Earnings Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - Forward P/E Multiple|Price to Future Earnings Ratio SXTC (China SXT Pharmaceuticals)|Forward P/E Multiple EPRX|Forward P/E Multiple bioharvest.com (BHST)|Future Price to Earnings Invizyne Technologies EXOZ|ORMP: Price to Future Earnings Ratio|ENTX: Projected Price to Earnings|HYFT: Future Price to Earnings|ABVC BioPharma Inc. (ABVC) - Future Price to Earnings|cumberlandpharma.com (CPIX) - Forward P/E Multiple|QNTM (Quantum BioPharma) - Forward P/E Multiple|FGEN: Future Price to Earnings Multiple|Forward P/E Multiple TELO|Forward P/E Multiple Rani Therapeutics Holdings (RANI)|Forward P/E Multiple SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Projected Price to Earnings Ratio|LEXX - Future Price to Earnings|PULM (Pulmatrix) - Price to Future Earnings Ratio|Pheton Holdings Ltd (PTHL) - Future Price to Earnings|Aptorum - Future Price to Earnings Multiple|Projected Price to Earnings LYRA|Projected Price to Earnings Impact BioMedical Inc (IBO)|Forward P/E Multiple TNFA|YCBD: Price to Expected Earnings Ratio|Future Price to Earnings PainReform PRFX|altamiratherapeutics.com (CYTO) - Projected Price to Earnings Ratio|LIPO: Projected Price to Earnings|OPTN (optinose.com) - Price to Future Earnings Ratio|PIRS: Forward P/E Multiple|PROC - Market Cap to Projected Earnings|PTPI (Petros Pharma) - Forward P/E Multiple|Future Price to Earnings QLI|Forward P/E Multiple SLRN|Market Cap to Future Earnings Ratio TFFP